Medical Inventi S.A.

Follow us
Medical Inventi S.A.

Medical Inventi Improving Lives

About us

About FlexiOss®

The world’s first flexible bone substitute biomaterial that integrates naturally into the patient’s bone.

The product stimulates bone reconstruction and growth, eliminating the need for a second operation to remove the implant, and significantly reducing patients’ pain and discomfort.

Read more

Areas of application

Orthopaedics and traumatology

Filling of bone defects in the limbs caused by trauma (e.g. fractures) and after removal of cancerous lesions or inflammatory […]

Read more

Dentistry

Treatment of bone defects in the oral cavity post e.g. tooth extraction, apex of the dental root resection, treatment of […]

Read more

Veterinary medicine

Filling bone defects resulting from trauma, surgical procedures or conditions such as osteomyelitis, hip dysplasia or bone tumours.

Read more

Breakthrough in regenerative medicine

Medical Inventi researches, creates, develops and commercialises innovative medical product solutions focusing on improving patients’ quality of life.

We are the exclusive owner of the know-how, technology and patents relating to FlexiOss®.

Get to know us better
Polski Produkt Przyszłości
Klaster Lubelska Medycyna
Klaster LifeScience Kraków

22.03.2025

Events

LSI USA Summit

From March 18th to 22nd, the LSI USA Summit – one of the most important events in the medtech industry […]

Read more

12.03.2025

Events

Tri-City Self-Government Congress in Lublin!

On Thursday, 13 March, Maciej Maniecki, President of Medical Inventi, took part in the Tri-City Self-Government Congress in Lublin! The […]

Read more

11.03.2025

Notices, Events

Partnership with the University of Bologna!

Great news! We are starting a partnership with the University of Bologna The University of Bologna – the oldest university […]

Read more

For investors

Investor relations aim to create and maintain effective communication between the Company and the investor community. The most important information for current and potential investors can be found here:

keyboard_arrow_up
Skip to content